For example, IL-33 can activate ILC2 in the lung, which promotes tumor burden by leading to innate type 2 inflammation and suppressing the production of IFN-γ and the cytotoxic functions of lung NK cells [116]. This evidence concerns the gene IL33 and neoplasm.